ACTIBIND, an actin-binding fungal T₂-RNase with antiangiogenic and anticarcinogenic characteristics

Keyphrases

• HT-29 100%
• Antiangiogenic 100%
• Actin Binding 100%
• Ribonuclease T2 100%
• Anticarcinogenic 100%
• Tumor 66%
• Cancer Cells 66%
• Actin Network 66%
• Matrigel 66%
• Human Umbilical Vein Endothelial Cells (HUVECs) 66%
• Angiogenin 66%
• Dimethylhydrazine 66%
• ZR-75-1 66%
• Athymic Mice 33%
• Cell Migration 33%
• Actin 33%
• Cell Motility 33%
• Incubation 33%
• Cell Surface 33%
• Cancer Development 33%
• Colon 33%
• Micropump 33%
• Breast 33%
• Intraperitoneal Injection 33%
• Aberrant Crypt Foci 33%
• Preventive Effect 33%
• Caco-2 33%
• Tumor Development 33%
• Colorectal Carcinogenesis 33%
• Human Colon 33%
• Therapeutic Effect 33%
• Invasion Assay 33%
• Microscopic Observation 33%
• Binding Activity 33%
• Xenograft Tumor 33%
• Basic Fibroblast Growth Factor (bFGF) 33%
• Endothelial Tube Formation 33%
• Aspergillus Niger 33%
• Carcinogenesis Models 33%
• Distal Colon 33%
• Microcapsules 33%
• Colonic Tumor 33%
• Tube Formation 33%
• Fibroblast Growth Factor 1 (FGF1) 33%
• Pollen Tube 33%
• Ribonuclease Activity 33%
• Mouse Xenograft Model 33%
• Cell Colony Formation 33%
• Tumor Blood Vessels 33%
• Cell Invasiveness 33%
• Subcutaneous Treatment 33%
• Extracellular nuclease 33%
• HT-29 Xenograft 33%

Medicine and Dentistry

• Actin 100%
• Ribonuclease 100%
• Antiangiogenic 100%
• Colon 60%
• Neoplasm 40%
• Cell Migration 40%
• Cancer Cell 40%
• Human Umbilical Vein Endothelial Cell 40%
• Matrigel 40%
• Angiogenin 40%
• Dimethylhydrazine 40%
• Malignant Neoplasm 20%
• Incubation 20%
• In Vitro 20%
• Cell Culture 20%
• Xenograft 20%
• Binding Affinity 20%
• Aberrant Crypt Foci 20%
• Colon Tumor 20%
• Cell Surface 20%
• Carcinogenesis 20%
• Colony Formation 20%
• Fibroblast Growth Factor 2 20%
• Caco-2 20%
• Vascular Tissue Neoplasm 20%
• Therapy Effect 20%
• Tumor Xenograft 20%
• Cell Motility 20%
• Aspergillus Niger 20%
• Fibroblast Growth Factor 1 20%
• Pollen Tube 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Actin 100%
• Antiangiogenic 100%
• Ribonuclease 100%
• Neoplasm 60%
• Malignant Neoplasm 60%
• Matrigel 40%
• Angiogenin 40%
• Dimethylhydrazine 40%
• Nude Mouse 20%
• Carcinogenesis 20%
• Aberrant Crypt Foci 20%
• Colon Tumor 20%
• Therapeutic Effect 20%
• Fibroblast Growth Factor 2 20%
• Aspergillus Niger 20%
• Vascular Tumor 20%
• Fibroblast Growth Factor 1 20%